These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
129 related articles for article (PubMed ID: 38604764)
41. Kline B; Yadav S; Seo Y; Ippisch RC; Castillo J; Aggarwal RR; Kelley RK; Behr SC; Flavell RR; Lawhn-Heath C; Melisko M; Rugo HS; Wang V; Yom SS; Ha P; Jiang F; Hope TA J Nucl Med; 2024 Jun; 65(6):938-943. PubMed ID: 38697672 [TBL] [Abstract][Full Text] [Related]
42. Translational imaging of the fibroblast activation protein (FAP) using the new ligand [ Backhaus P; Gierse F; Burg MC; Büther F; Asmus I; Dorten P; Cufe J; Roll W; Neri D; Cazzamalli S; Millul J; Mock J; Galbiati A; Zana A; Schäfers KP; Hermann S; Weckesser M; Tio J; Wagner S; Breyholz HJ; Schäfers M Eur J Nucl Med Mol Imaging; 2022 May; 49(6):1822-1832. PubMed ID: 34957527 [TBL] [Abstract][Full Text] [Related]
43. [ Zhang P; Zhao Z; Zhang L; Wu W; Xu Y; Pan D; Wang F; Yang M Nucl Med Biol; 2019; 74-75():19-24. PubMed ID: 31450071 [TBL] [Abstract][Full Text] [Related]
44. Differential uptake of (68)Ga-DOTATOC and (68)Ga-DOTATATE in PET/CT of gastroenteropancreatic neuroendocrine tumors. Poeppel TD; Binse I; Petersenn S; Lahner H; Schott M; Antoch G; Brandau W; Bockisch A; Boy C Recent Results Cancer Res; 2013; 194():353-71. PubMed ID: 22918768 [TBL] [Abstract][Full Text] [Related]
45. Synthesis and evaluation of a novel 68Ga-chelate-conjugated bisphosphonate as a bone-seeking agent for PET imaging. Suzuki K; Satake M; Suwada J; Oshikiri S; Ashino H; Dozono H; Hino A; Kasahara H; Minamizawa T Nucl Med Biol; 2011 Oct; 38(7):1011-8. PubMed ID: 21982572 [TBL] [Abstract][Full Text] [Related]
46. Synthesis, preclinical validation, dosimetry, and toxicity of 68Ga-NOTA-anti-HER2 Nanobodies for iPET imaging of HER2 receptor expression in cancer. Xavier C; Vaneycken I; D'huyvetter M; Heemskerk J; Keyaerts M; Vincke C; Devoogdt N; Muyldermans S; Lahoutte T; Caveliers V J Nucl Med; 2013 May; 54(5):776-84. PubMed ID: 23487015 [TBL] [Abstract][Full Text] [Related]
47. Noninvasive Classification of Human Triple Negative Breast Cancer by PET Imaging with GRP78-Targeted Molecular Probe [ Zhao H; Meng H; Wen J; Wang C; Liu J; Huang G Mol Imaging Biol; 2020 Jun; 22(3):772-779. PubMed ID: 31452065 [TBL] [Abstract][Full Text] [Related]
48. Preclinical study and first-in-human imaging of [ Liu L; Zhong J; Zhang Z; Ye X; Wang X; Liu S; Zhang Z Eur J Nucl Med Mol Imaging; 2024 Jun; 51(7):2012-2022. PubMed ID: 38326656 [TBL] [Abstract][Full Text] [Related]
49. Dual-Modality Imaging of Prostate Cancer with a Fluorescent and Radiogallium-Labeled Gastrin-Releasing Peptide Receptor Antagonist. Zhang H; Desai P; Koike Y; Houghton J; Carlin S; Tandon N; Touijer K; Weber WA J Nucl Med; 2017 Jan; 58(1):29-35. PubMed ID: 27516447 [TBL] [Abstract][Full Text] [Related]
58. Characterization of a 67Ga/68Ga radiopharmaceutical for SPECT and PET of MDR1 P-glycoprotein transport activity in vivo: validation in multidrug-resistant tumors and at the blood-brain barrier. Sharma V; Prior JL; Belinsky MG; Kruh GD; Piwnica-Worms D J Nucl Med; 2005 Feb; 46(2):354-64. PubMed ID: 15695797 [TBL] [Abstract][Full Text] [Related]
59. Head-to-head intra-individual comparison of biodistribution and tumor uptake of Giesel FL; Kratochwil C; Schlittenhardt J; Dendl K; Eiber M; Staudinger F; Kessler L; Fendler WP; Lindner T; Koerber SA; Cardinale J; Sennung D; Roehrich M; Debus J; Sathekge M; Haberkorn U; Calais J; Serfling S; Buck AL Eur J Nucl Med Mol Imaging; 2021 Dec; 48(13):4377-4385. PubMed ID: 34137945 [TBL] [Abstract][Full Text] [Related]
60. Targeting of MMP2 activity in malignant tumors with a 68Ga-labeled gelatinase inhibitor cyclic peptide. Liu Q; Pan D; Cheng C; Zhang A; Ma C; Wang L; Zhang D; Liu H; Jiang H; Wang T; Xu Y; Yang R; Chen F; Yang M; Zuo C Nucl Med Biol; 2015 Dec; 42(12):939-44. PubMed ID: 26344861 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]